InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Enliven Therapeutics, Inc.

ELVN Clue Score23
United States Fiscal year ends December CIK 0001672619 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

103
Insider
Date
Role
Action
Shares
Price
Amount
Helen Louise Collins
19 Oct 2026
Chief Medical Officer
Sold after exercise
5,000
$38.47
$192.34K
Benjamin Hohl
19 Oct 2026
Chief Financial Officer
Sold after exercise
6,018
$38.48
$231.55K
J. Scott Garland
1 Oct 2026
Director
Sold after exercise
13,000
$46.67
$606.72K
Helen Louise Collins
17 Sep 2026
Chief Medical Officer
Sold after exercise
240
$51.48
$12.36K
Helen Louise Collins
17 Sep 2026
Chief Medical Officer
Sold after exercise
1,844
$50.71
$93.51K
Helen Louise Collins
17 Sep 2026
Chief Medical Officer
Sold after exercise
2,916
$50.03
$145.89K
Benjamin Hohl
17 Sep 2026
Chief Financial Officer
Sold after exercise
289
$51.49
$14.88K
Benjamin Hohl
17 Sep 2026
Chief Financial Officer
Sold after exercise
2,194
$50.72
$111.27K
Benjamin Hohl
17 Sep 2026
Chief Financial Officer
Sold after exercise
3,535
$50.03
$176.85K
Helen Louise Collins
17 Aug 2026
Chief Medical Officer
Sold after exercise
1,100
$59.35
$65.28K
Helen Louise Collins
17 Aug 2026
Chief Medical Officer
Sold after exercise
3,900
$58.37
$227.65K
Mika K Derynck
4 Aug 2026
Director
Sold after exercise
158,795
$60.21
$9.56M
Helen Louise Collins
17 Jul 2026
Chief Medical Officer
Sold after exercise
63
$53.92
$3.40K
Helen Louise Collins
17 Jul 2026
Chief Medical Officer
Sold after exercise
2,184
$53.42
$116.67K
Helen Louise Collins
17 Jul 2026
Chief Medical Officer
Sold after exercise
2,063
$52.39
$108.08K
Helen Louise Collins
17 Jul 2026
Chief Medical Officer
Sold after exercise
459
$51.55
$23.66K
Helen Louise Collins
17 Jul 2026
Chief Medical Officer
Sold after exercise
231
$50.05
$11.56K
Benjamin Hohl
17 Jul 2026
Chief Financial Officer
Sold after exercise
123
$53.87
$6.63K
Benjamin Hohl
17 Jul 2026
Chief Financial Officer
Sold after exercise
2,638
$53.38
$140.82K
Benjamin Hohl
17 Jul 2026
Chief Financial Officer
Sold after exercise
2,564
$52.32
$134.14K
Benjamin Hohl
17 Jul 2026
Chief Financial Officer
Sold after exercise
369
$51.48
$19.00K
Benjamin Hohl
17 Jul 2026
Chief Financial Officer
Sold after exercise
324
$49.97
$16.19K
Helen Louise Collins
17 Jun 2026
Chief Medical Officer
Sold after exercise
1,133
$44.74
$50.69K
Helen Louise Collins
17 Jun 2026
Chief Medical Officer
Sold after exercise
2,599
$43.87
$114.02K
Helen Louise Collins
17 Jun 2026
Chief Medical Officer
Sold after exercise
1,268
$42.83
$54.30K
Benjamin Hohl
17 Jun 2026
Chief Financial Officer
Sold after exercise
1,238
$44.75
$55.40K
Benjamin Hohl
17 Jun 2026
Chief Financial Officer
Sold after exercise
3,401
$43.86
$149.18K
Benjamin Hohl
17 Jun 2026
Chief Financial Officer
Sold after exercise
1,379
$42.79
$59.00K
Helen Louise Collins
18 May 2026
Chief Medical Officer
Sold after exercise
223
$41.21
$9.19K
Helen Louise Collins
18 May 2026
Chief Medical Officer
Sold after exercise
1,302
$40.25
$52.40K
Helen Louise Collins
18 May 2026
Chief Medical Officer
Sold after exercise
3,475
$39.53
$137.38K
Helen Louise Collins
17 Apr 2026
Chief Medical Officer
Sold after exercise
2,441
$48.06
$117.30K
Helen Louise Collins
17 Apr 2026
Chief Medical Officer
Sold after exercise
2,419
$47.39
$114.64K
Helen Louise Collins
17 Apr 2026
Chief Medical Officer
Sold after exercise
140
$45.81
$6.41K
Helen Louise Collins
25 Mar 2026
Chief Medical Officer
Sold after exercise
40,000
$35.10
$1.40M
Helen Louise Collins
17 Mar 2026
Chief Medical Officer
Sold after exercise
5,000
$27.76
$138.80K
Helen Louise Collins
10 Mar 2026
Chief Medical Officer
Sold after exercise
10,129
$30.19
$305.83K
Helen Louise Collins
9 Mar 2026
Chief Medical Officer
Sold after exercise
29,871
$30.02
$896.81K
Helen Louise Collins
17 Feb 2026
Chief Medical Officer
Sold after exercise
45,000
$26.17
$1.18M
Benjamin Hohl
29 Sep 2025
Chief Financial Officer
Sold after exercise
3,250
$20.40
$66.29K
Benjamin Hohl
27 Aug 2025
Chief Financial Officer
Sold after exercise
3,250
$20.63
$67.04K
Benjamin Hohl
28 Jul 2025
Chief Financial Officer
Sold after exercise
65
$21.30
$1.38K
Benjamin Hohl
28 Jul 2025
Chief Financial Officer
Sold after exercise
3,185
$20.45
$65.12K
Benjamin Hohl
10 Jul 2025
Chief Financial Officer
Sold after exercise
1,000
$22.66
$22.66K
Benjamin Hohl
27 Jun 2025
Chief Financial Officer
Sold after exercise
198
$21.66
$4.29K
Benjamin Hohl
27 Jun 2025
Chief Financial Officer
Sold after exercise
3,052
$20.86
$63.67K
Benjamin Hohl
13 Jun 2025
Chief Financial Officer
Sold after exercise
3,000
$22.55
$67.66K
Benjamin Hohl
27 May 2025
Chief Financial Officer
Sold after exercise
3,250
$16.18
$52.59K
Benjamin Hohl
28 Apr 2025
Chief Financial Officer
Sold after exercise
69
$19.12
$1.32K
Benjamin Hohl
28 Apr 2025
Chief Financial Officer
Sold after exercise
3,181
$18.68
$59.42K
Benjamin Hohl
27 Mar 2025
Chief Financial Officer
Sold after exercise
3,250
$21.33
$69.32K
Benjamin Hohl
24 Mar 2025
Chief Financial Officer
Sold after exercise
1,000
$22.50
$22.50K
Benjamin Hohl
27 Feb 2025
Chief Financial Officer
Sold after exercise
3,250
$20.41
$66.33K
Benjamin Hohl
5 Feb 2025
Chief Financial Officer
Sold after exercise
1,000
$22.52
$22.52K
Benjamin Hohl
27 Jan 2025
Chief Financial Officer
Sold after exercise
3,250
$21.59
$70.18K
Anish Patel
7 Jan 2025
Chief Operating Officer
Sold after exercise indirect
90
$24.60
$2.21K
Anish Patel
7 Jan 2025
Chief Operating Officer
Sold after exercise indirect
6,577
$24.17
$158.96K
Anish Patel
7 Jan 2025
Chief Operating Officer
Sold after exercise
1,440
$24.56
$35.37K
Anish Patel
7 Jan 2025
Chief Operating Officer
Sold after exercise
20,260
$24.15
$489.33K
Benjamin Hohl
3 Jan 2025
Chief Financial Officer
Sold after exercise
1,000
$25.04
$25.04K
Benjamin Hohl
30 Dec 2024
Chief Financial Officer
Sold after exercise
900
$22.51
$20.26K
Benjamin Hohl
27 Dec 2024
Chief Financial Officer
Sold after exercise
3,350
$22.15
$74.22K
Benjamin Hohl
27 Nov 2024
Chief Financial Officer
Sold after exercise
1,000
$25.38
$25.38K
Benjamin Hohl
27 Nov 2024
Chief Financial Officer
Sold after exercise
4,250
$24.78
$105.31K
Benjamin Hohl
28 Oct 2024
Chief Financial Officer
Sold after exercise
650
$29.11
$18.92K
Benjamin Hohl
28 Oct 2024
Chief Financial Officer
Sold after exercise
5,600
$28.49
$159.56K
Helen Louise Collins
18 Oct 2024
Chief Medical Officer
Sold after exercise
816
$30.00
$24.48K
Benjamin Hohl
18 Oct 2024
Chief Financial Officer
Sold after exercise
814
$30.00
$24.42K
Rahul D. Ballal
8 Oct 2024
Director
Sold after exercise
10,420
$28.17
$293.56K
Benjamin Hohl
7 Oct 2024
Chief Financial Officer
Sold after exercise
1,270
$27.51
$34.94K
Benjamin Hohl
4 Oct 2024
Chief Financial Officer
Sold after exercise
10,218
$27.51
$281.08K
Benjamin Hohl
1 Oct 2024
Chief Financial Officer
Sold after exercise
521
$27.54
$14.35K
Benjamin Hohl
30 Sep 2024
Chief Financial Officer
Sold after exercise
2,000
$25.33
$50.67K
Benjamin Hohl
27 Sep 2024
Chief Financial Officer
Sold after exercise
4,250
$24.27
$103.16K
Benjamin Hohl
27 Aug 2024
Chief Financial Officer
Sold after exercise
4,250
$22.54
$95.78K
Benjamin Hohl
31 Jul 2024
Chief Financial Officer
Sold after exercise
991
$27.53
$27.28K
Benjamin Hohl
29 Jul 2024
Chief Financial Officer
Sold after exercise
61
$27.44
$1.67K
Benjamin Hohl
29 Jul 2024
Chief Financial Officer
Sold after exercise
5,189
$26.67
$138.38K
Benjamin Hohl
12 Jul 2024
Chief Financial Officer
Sold after exercise
3,000
$25.07
$75.20K
Benjamin Hohl
27 Jun 2024
Chief Financial Officer
Sold after exercise
1,140
$23.43
$26.71K
Benjamin Hohl
27 Jun 2024
Chief Financial Officer
Sold after exercise
1,830
$22.58
$41.31K
Benjamin Hohl
27 Jun 2024
Chief Financial Officer
Sold after exercise
1,280
$21.79
$27.90K
Anish Patel
6 Jun 2024
Chief Operating Officer
Sold after exercise
1,133
$20.06
$22.72K
Joseph P Lyssikatos
29 May 2024
Chief Scientific Officer
Sold after exercise
2,123
$22.52
$47.81K
Joseph P Lyssikatos
29 May 2024
Chief Scientific Officer
Sold after exercise
9,877
$21.56
$212.99K
Benjamin Hohl
28 May 2024
Chief Financial Officer
Sold after exercise
10
$24.34
$243.40
Benjamin Hohl
28 May 2024
Chief Financial Officer
Sold after exercise
2,334
$23.42
$54.66K
Benjamin Hohl
28 May 2024
Chief Financial Officer
Sold after exercise
1,906
$22.89
$43.63K
Samuel Kintz
28 May 2024
President and CEO
Sold after exercise
100
$24.34
$2.43K
Samuel Kintz
28 May 2024
President and CEO
Sold after exercise
5,219
$23.57
$123.02K
Samuel Kintz
28 May 2024
President and CEO
Sold after exercise
6,681
$22.86
$152.76K
Anish Patel
14 May 2024
Chief Operating Officer
Sold after exercise
1,107
$25.00
$27.68K
Anish Patel
9 May 2024
Chief Operating Officer
Sold after exercise
260
$25.06
$6.52K
Anish Patel
6 May 2024
Chief Operating Officer
Sold after exercise
4,875
$22.72
$110.77K
Benjamin Hohl
3 May 2024
Chief Financial Officer
Sold after exercise
1,000
$22.50
$22.50K
Benjamin Hohl
29 Apr 2024
Chief Financial Officer
Sold after exercise
3,250
$16.97
$55.16K
Joseph P Lyssikatos
29 Apr 2024
Chief Scientific Officer
Sold after exercise
1,013
$18.48
$18.72K
Joseph P Lyssikatos
29 Apr 2024
Chief Scientific Officer
Sold after exercise
10,987
$17.86
$196.27K
Samuel Kintz
25 Apr 2024
President and CEO
Sold after exercise
12,000
$16.89
$202.70K
Rahul D. Ballal
11 Apr 2024
Director
Sold after exercise
3,068
$25.21
$77.34K
Rahul D. Ballal
11 Apr 2024
Director
Sold after exercise
20,032
$25.00
$500.70K
Rahul D. Ballal
11 Apr 2024
Director
Sold after exercise
30,300
$23.14
$701.02K
Helen Louise Collins
11 Apr 2024
Chief Medical Officer
Sold after exercise
20,000
$25.07
$501.48K
Showing 250 of 414 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 327
Amendments (4/A) skipped 10
Filings about a different issuer 0
Unreadable filings 0
Joint filings 32
Sales on a Rule 10b5-1 plan 150
Sales straight out of an exercise 150
Sales at will 64
Transactions with no price 0
Shares from compensation/vesting 45,234,647
Sales filed before the plan box existed 44
History held since 16 Mar 2020